现货大促销,价格低至8折起,量大更优惠,详细咨询客服
全部分类
全部分类
  • INCB28060(Capmatinib)的轮播介绍
INCB28060(Capmatinib)的可视化放大

INCB28060(Capmatinib)

原价
¥1119.00-5414.00
价格
780.00-3000.00

所有产品仅用作科学研究,我们不为任何个人用途提供产品和服务

询价有惊喜,量大更优惠 点击这里给我发消息

可选包装 >>>
首页

C-Met inhibitor,ATP-competitive and novel

货号:ajci19974
CAS:1029712-80-8
分子式:C23H17FN6O
分子量:412.42
纯度:98%
存储:Store at -20°C
库存:现货

Background:

INCB28060, also known as Capmatinib and INC280, is a novel and ATP-competitive inhibitor of c-Met with IC50 of 0.13 nM.


c-Met, also named as hepatocyte growth factor receptor (HGFR) is a receptor tyrosine kinase that is essential for embryonic development and would healing. In many tumor cells, this molecular is overexpressed or mutated and was found to play important roles in tumor cell proliferation, survival, invasion, metastasis and angiogenesis.


In vitro, INCB28060 treatment effectively inhibited activation of c-MET and signaling in cancer cells. As a result, INCB28060 blocked cell proliferation of varying cell lines such as SNU-5 and S114. The cell migration of U-87MG and H441 cells were also highly inhibited1.


The role of c-met was studied using this inhibitor in mouse model. Oral administration of INCB28060 leads to inhibition of c-MET phosphorylation and tumor growth in c-MET-driven mouse tumor models. Therefore, INCB28060 has the therapeutic potential in cancer treatment 1.


Reference:
1.   Liu X, Wang Q, Yang G, et al. A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011;17(22):7127-7138.


动态评分

0.0

没有评分数据
没有评价数据
一键回到顶部
展开 收缩

安捷凯在线客服